CLINICAL_TRIALS
trial_result
· 2018-10-30
Clinical Trial Update: An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial update for VTP-43742 in healthy volunteers and patients with psoriasis, completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vitae Pharmaceuticals Inc., an Allergan affiliate | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED